Sebastien Aguettant, president of the French Association of Pharmaceutical Contract Manufacturers (SPIS) and president of leading French CMO Delpharm, discusses the evolutions and growing significance of contract manufacturing, how CMO pharma manufacturing has only just begun, and how Delpharm with its ten sites in France is a reliable partner of choice.
What have been the key milestones in the development of Delpharm as a French manufacturing success story?
In my opinion, the trend of CMO pharma manufacturing has only just begun
